NCT05693220

Brief Summary

This is a randomized controlled trial comparing density gradient centrifugation and microfluidic sperm sorting in patients undergoing intrauterine insemination to evaluate cumulative pregnancy outcomes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
270

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 9, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 20, 2023

Completed
16 days until next milestone

Study Start

First participant enrolled

February 5, 2023

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 3, 2023

Status Verified

March 1, 2023

Enrollment Period

2.9 years

First QC Date

December 9, 2022

Last Update Submit

March 30, 2023

Conditions

Keywords

Intrauterine InseminationInseminationFertilityInfertility

Outcome Measures

Primary Outcomes (1)

  • Cumulative clinical pregnancy rate

    The clinical pregnancy rate by treatment group over the course of IUI treatment

    3 treatment cycles, an average of 5 months

Study Arms (2)

Density gradient centrifugation

ACTIVE COMPARATOR

Patients will undergo sperm preparation by density gradient centrifugation

Other: Density gradient centrifugation

Zymot sperm separation device

ACTIVE COMPARATOR

Patients will undergo sperm preparation by the Zymot sperm separation device

Device: Zymot Multi sperm separation device

Interventions

Sperm preparation with Zymot Multi sperm preparation device

Zymot sperm separation device

Sperm preparation with density gradient centrifugation

Density gradient centrifugation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing intrauterine insemination
  • Patient assigned female at birth with age \<41

You may not qualify if:

  • Any significant disease or psychiatric disorder that would interfere with the consenting process
  • Prior intrauterine insemination
  • Use of frozen donor sperm
  • Non-English speaker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCSF Center for Reproductive Health

San Francisco, California, 94158, United States

RECRUITING

Related Publications (2)

  • Gode F, Bodur T, Gunturkun F, Gurbuz AS, Tamer B, Pala I, Isik AZ. Comparison of microfluid sperm sorting chip and density gradient methods for use in intrauterine insemination cycles. Fertil Steril. 2019 Nov;112(5):842-848.e1. doi: 10.1016/j.fertnstert.2019.06.037. Epub 2019 Sep 19.

    PMID: 31543253BACKGROUND
  • Quinn MM, Jalalian L, Ribeiro S, Ona K, Demirci U, Cedars MI, Rosen MP. Microfluidic sorting selects sperm for clinical use with reduced DNA damage compared to density gradient centrifugation with swim-up in split semen samples. Hum Reprod. 2018 Aug 1;33(8):1388-1393. doi: 10.1093/humrep/dey239.

    PMID: 30007319BACKGROUND

MeSH Terms

Conditions

InfertilityAnovulation

Interventions

Centrifugation, Density Gradient

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital DiseasesOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsGonadal DisordersEndocrine System Diseases

Intervention Hierarchy (Ancestors)

UltracentrifugationCentrifugationInvestigative TechniquesChemistry Techniques, Analytical

Study Officials

  • Mitchell Rosen, MD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alisha T Tolani, MD

CONTACT

Elena Hoskin

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2022

First Posted

January 20, 2023

Study Start

February 5, 2023

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

April 3, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations